Rating scales for dyskinesias in Parkinson's disease

Movement Disorders

Volumn 14, Issue SUPPL. 1, 1999, Pages 48-53

  Goetz, Christopher G ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

CONFERENCE PAPER; DENERVATION; DIAGNOSTIC VALUE; DOPAMINERGIC NERVE CELL; DYSKINESIA; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; PARKINSON DISEASE; PHENOMENOLOGY; PRIORITY JOURNAL; RATING SCALE;

ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 0032750415     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Marsden CD. 'On-off' phenomena in Parkinson's disease. In: Rinne UK, Linger M, Stamm G, eds. Parkinson's Disease: Current Progress, Problems and Management. New York, NY: Elsevier/ North-Holland Biomedical Press, 1980:241-254.
2. Colosimo C, Merello M, Hughes AJ, et al. Motor response to acute dopaminergic challenge with apomorphine and L-dopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon. J Neurol Neurosurg Psychiatry 1996;61:634-637.
3. Fabbrini G, Mouradian MM, Juncos JL, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms. Part I. Ann Neurol 1988;24:366-371.
4. Nutt JG, Carter JH, Lea ES, Woodward WR. Motor fluctuations during continuous L-dopa infusions in patients with Parkinson's disease. Mov Disord 1997;12:285-292.
5. Mouradian MM, Juncos JL, Fabbrini G, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanism. Part II. Ann Neurol 1988;24:372-378.
6. Metman LV, van den Mundkhof P, Klaassen AAG, et al. Effects of supra-threshold L-dopa doses on dyskinesias in advanced Parkinson's disease. Neurology 1997;49:711-713.
7. Greenamyre JT, O'Brien CF. NMDA agonists in the treatment of Parkinson's disease. Arch Neurol 1991;48:977-981.
8. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of Gpi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
9. Rocco NG. Statistical and methodologic considerations in scale construction. In: Munsat TL, ed. Quantification of Neurologic Deficit. Boston, MA: Butterworth, 1989:49-67.
10. Kurtzke J. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1993;33: 1444-1452.
11. Nutt JG, Woodward WR, Hammerstad JP, et al. The 'on-off' phenomenon in Parkinson's disease: relation to L-dopa absorption and transport. N Engl J Med 1984;310:483-488.
12. Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, Clark A, Shoulson I. Duodenal delivery of L-dopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 1986;20:262-265.
13. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Government Printing Office, 1976.
14. Gardos G, Cole JO, Rapkin RM. Anticholinergic challenge and neuroleptic withdrawal. Arch Gen Psychiatry 1984;41:1030-1035.
15. Mouradian MM, Heuser IJE, Baronti F, et al. Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 1989;25:523-526.
16. Bonifati V, Fabrizio E, Cipriani R, et al. Buspirone in L-dopa-induced dyskinesias. Clin Neuropharmacol 1994;17:73-82.
17. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CO, Calne DB, Goldstein M, eds. Recent Development in Parkinson's Disease, vol 2. Florham Park, NJ: MacMillan Health Care Information, 1987:153-164.
18. Goetz CG, Stebbins GT, Blasucci LM, Grobman MS. Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease. Mov Disord 1997;12:1039-1041.
19. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic L-dopa therapy in Parkinson's disease. Neurology 1989;39(suppl 2): 11-19.
20. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). In: Lindvall O, Bjorklund A, Widner H, eds. Intracerebral Transplantation in Movement Disorders. Amsterdam, The Netherlands: Elsevier, 1991:227-241.
21. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesias rating scale for Parkinson's disease inter- and intrarater reliability assessment. Mov Disord 1994;9:390-394.
22. Brown RG, MacCarthy B, Johanshahi M, Marsden CD. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989;46:955-959.
23. Caligiuri MP, Lohr JB. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesias in the hand. J Neuropsychiatry Clin Neurosci 1990;2:395-398.
24. Caligiuri MP, Peterson S. A quantitative study of L-dopa-induced dyskinesias in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993;6:89-98.